Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Enzyme Inhibition and Medicinal Chemistry|February 23, 2021
Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolonesPerihan A Elzahhar, Rana A Alaaeddine, Rasha Nassra, et al.
European Journal of Medicinal Chemistry|January 1, 2018
Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking studyGhandoura Moussa, Rana Alaaeddine, Lynn M Alaeddine, et al.
Bioorganic Chemistry|February 7, 2020
Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studiesNayera W Hassan, Manal N Saudi, Yasser S Abdel-Ghany, et al.
BMJ Neurology Open|March 8, 2021
Effect of remote ischaemic preconditioning on walking in people with multiple sclerosis: double-blind randomised controlled trialChayaporn Chotiyarnwong, Krishnan Nair, Lorenza Angelini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2023
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensusPriyanka Iyer, Kate Wiles, Azza Ismail, et al.
European Journal of Medicinal Chemistry|March 1, 2019
Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazonesPerihan A Elzahhar, Rana Alaaeddine, Tamer M Ibrahim, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72Azza Ismail, Johnathan Cooper-Knock, J Robin Highley, et al.
European Journal of Medicinal Chemistry|March 1, 2025
Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammationMai S El-Shoukrofy, Azza Ismail, Reem H Elhamammy, et al.
Pageof 3